These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 221885)

  • 1. [The prevention of chickenpox in high risk children. Comparison of the effectiveness of specific immunoglobulins and of defibrinated convalescent plasma. 414 cases (author's transl)].
    Avenard G; Gaiffe M; Herzog F
    Nouv Presse Med; 1979 Feb; 8(9):673-5. PubMed ID: 221885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Use of specific intravenous varicella-zoster immunoglobulins in the prevention of varicella in immunocompromised children: clinical and serological evaluation].
    Macchia P; Favre C; Nardi M; Consolini R; Conaldi PG; Bendinelli M
    Minerva Pediatr; 1987 Oct; 39(20):813-20. PubMed ID: 2830480
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prevention of varicella in immunocompromised children. Clinical and serological evaluation of specific anti-varicella-zoster immunoglobulins].
    Macchia P; Abadessa A; Nardi M; Consolini R; Conaldi PG; Bendinelli M
    Minerva Pediatr; 1984 Nov; 36(21):1053-7. PubMed ID: 6099463
    [No Abstract]   [Full Text] [Related]  

  • 4. [Preventive and therapeutic effect convalescent zona and varicella sera in high risk children (659 cases)].
    Gaiffe M; Herzog F; Schweisguth O
    Nouv Presse Med; 1976 May; 5(20):1285-8. PubMed ID: 59342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Varicella-zoster-immunoglobulin as a safe prophylaxis of varicella (author's transl)].
    Kornhuber B; Kropp H; Ribeiro-Ayeh J; Hinderfeld L; Welte K
    Monatsschr Kinderheilkd; 1982 Jan; 130(1):27-9. PubMed ID: 6278297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Letter: Prevention against varicella and herpes zoster in individuals with impaired immunological defence].
    Moe FJ
    Tidsskr Nor Laegeforen; 1974 Dec; 94(34-36):2409. PubMed ID: 4374773
    [No Abstract]   [Full Text] [Related]  

  • 7. [Chickenpox prevention in patients at risk with a special immunoglobulin].
    Thomas E; Enders-Ruckle G; Geursen RG
    Klin Padiatr; 1985; 197(5):415-8. PubMed ID: 2999501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prevention of varicella in children on immunosuppressive therapy (author's transl)].
    Kornhuber B; Kropp H; Ribeiro-Ayeh J
    Klin Padiatr; 1980 Mar; 192(2):154-6. PubMed ID: 7191452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Acyclovir and specific anti-varicella-herpes zoster immunoglobulins in the treatment of varicella-zoster virus infection in 113 adults].
    Senneville E; Chidiac C; Brouillard M; Beuscart C; Leroy O; Sivery B; Beaucaire G; Mouton Y
    Pathol Biol (Paris); 1990 Jun; 38(5 ( Pt 2)):568-71. PubMed ID: 2166935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zoster immune globulin for immunosuppressed children.
    Lane RS; Rankin A; Kay HE
    Lancet; 1980 Mar; 1(8170):705-6. PubMed ID: 6103108
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevention of varicella in urgent cases by passive transfer of vaccine-induced immunity.
    Baba K; Tsuda N; Yabuuchi H; Konishi S; Fujinami A; Tsujino G; Takahashi M
    Biken J; 1980 Jun; 23(2):89-94. PubMed ID: 6257226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Polyvalent immunoglobulins in prevention of viral infections in children with neoplastic diseases treated with immunosuppressive therapy].
    Graf N; Hille A; Jost W; Müller J
    Padiatr Padol; 1991; 26(4):187-91. PubMed ID: 1749627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of varicella in immunocompromised patients on unpredictable occurrence of the disease in a children's ward: vaccine-boostered immune whole blood transfusion (VIB) method.
    Hirao T
    Biken J; 1984 Sep; 27(2-3):137-41. PubMed ID: 6100052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Live attenuated varicella vaccine use in immunocompromised children and adults.
    Gershon AA; Steinberg SP; Gelb L
    Pediatrics; 1986 Oct; 78(4 Pt 2):757-62. PubMed ID: 3020495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zoster immune globulin. Regional production and allocation.
    Ross AH; Klein SW; McKennett B; Kraminer A; Caifa K
    N Y State J Med; 1974 Jul; 74(8):1367-72. PubMed ID: 4528120
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevention of varicella in high risk children: a collaborative study.
    Brunell PA; Gershon AA; Hughes WT; Riley HD; Smith J
    Pediatrics; 1972 Nov; 50(5):718-22. PubMed ID: 5084186
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevention of varicella: recommendations for use of varicella vaccines in children, including a recommendation for a routine 2-dose varicella immunization schedule.
    American Academy of Pediatrics Committee on Infectious Diseases
    Pediatrics; 2007 Jul; 120(1):221-31. PubMed ID: 17606582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous hyperimmunoglobulin to prevent varicella-zoster infection.
    Goebel U; Schwamborn D; Moeller B; Juergens H
    Pediatr Infect Dis J; 1987 Feb; 6(2):224. PubMed ID: 3031577
    [No Abstract]   [Full Text] [Related]  

  • 19. Expanded guidelines for use of varicella-zoster immune globulin.
    Pediatrics; 1983 Dec; 72(6):886-9. PubMed ID: 6316247
    [No Abstract]   [Full Text] [Related]  

  • 20. Therapeutic use of zoster-immune plasma: A report of 8 cases.
    Dickson DN; Heath M
    S Afr Med J; 1979 Sep; 56(12):491-4. PubMed ID: 550378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.